Liquidia is deeply passionate and committed to the discovery, engineering, and development required to bring novel therapies to patients who need them most, and to the healthcare providers who care for them. Our current drive is toward improving the treatment of pulmonary hypertension (PH). We will continue to combine our proprietary, innovative PRINT® Technology with new and established medications, offering the potential for both better precision and improved clinical outcomes. Our team members include some of the industry’s top scientists, clinicians, business strategists, engineers, and pharmaceutical executives. We work together to help people lead longer, healthier, and happier lives.
Location: This position may be performed remotely but requires flexibility and willingness to travel as needed.
Liquidia Technologies seeks a dedicated and detail-oriented Medical Information Manager to join our dynamic Research Triangle Park (RTP), NC team. As a key contributor to our Medical Affairs department, you will be crucial in authoring and disseminating accurate, current, and fair-balanced scientific and medical information. Your expertise will help ensure that healthcare professionals and patients receive timely and reliable information, ultimately enhancing patient outcomes. In this role, you will own the development and maintenance of standard medical response documents and the company’s medical information repository, ensuring healthcare professionals, patients, and internal partners receive timely, evidence-based responses to medical inquiries about Liquidia’s products. Provide off-hours support for urgent medical inquiries and represent Medical Affairs at scientific congresses through booth engagements.
This role also supports the Medical, Legal, and Regulatory (MLR) review of promotional and scientific materials and contributes to Medical Education initiatives. You will serve as the primary lead for Medical in the Publication Review Committee (PRC), overseeing the review and approval of scientific publications and promotional materials to ensure accuracy and compliance. The Medical Information Manager safeguards scientific and regulatory integrity across all communications while helping Medical Affairs serve as a trusted resource across the organization. The ability to synthesize complex data and communicate effectively will be essential in supporting our mission to develop innovative therapies for rare and life-threatening diseases.
This role will also monitor scientific literature and communicate new data to relevant internal groups. This role will develop, organize, and maintain the company’s repository of standard medical responses, FAQs, and reference materials. Management of the copyright clearinghouse, RightFind, and publication library, Endnote, is necessary to communicate and house relevant information.
Medical Inquiries:
Promotional and Scientific Materials:
Medical Inquiries Resource Development and Support:
Regulatory Compliance:
Liquidia offers a competitive compensation package as well as a comprehensive benefits package that includes Medical, Dental, Vision, STD, LTD, 401(k) Savings Retirement Plan, ESPP, and more!
Liquidia is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status. Reasonable accommodation may be made to enable qualified individuals with disabilities to perform the essential functions of this position.
Liquidia will not accept unsolicited assistance from recruiting/search agencies for this employment opportunity. Please, no phone calls or emails. All resumes submitted by recruiting or search agencies to any employee at Liquidia via email, the Internet or in any form and/or method without a valid written search/recruitment agreement in place for this position will be deemed the sole property of Liquidia. No fee will be paid in the event the candidate is hired by Liquidia as a result of the referral or through other means.

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. Liquidia has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Liquidia is also developing L606, an investigational liposomal formulation of treprostinil administered twice-daily with a short-duration next-generation nebulizer, for use in North America. The subsidiary Liquidia PAH provides for the commercialization of pharmaceutical products to treat pulmonary disease, such as generic Treprostinil Injection.